Search

Your search keyword '"Ophthalmic Solutions administration & dosage"' showing total 2,765 results

Search Constraints

Start Over You searched for: Descriptor "Ophthalmic Solutions administration & dosage" Remove constraint Descriptor: "Ophthalmic Solutions administration & dosage"
2,765 results on '"Ophthalmic Solutions administration & dosage"'

Search Results

1. Reactive Oxygen Species Responsive Supramolecular Prodrug Eyedrops for the Treatment of Choroidal Neovascularization.

2. Hydrogel-Embedded Polydimethylsiloxane Contact Lens for Ocular Drug Delivery.

3. Elucidating acceptance and clinical indications to support the rational design of drug-eluting contact lenses.

4. Study of the establishment of a guinea pig model of ocular accommodative spasm by carbachol eye drops.

5. In Situ Gelling Eye Drops of Tacrolimus with Improved Ocular Delivery and Therapeutic Efficacy.

6. Self-assembled latanoprost loaded soluplus nanomicelles as an ophthalmic drug delivery system for the management of glaucoma.

7. The effects of topical latanoprost 0.005% treatment on microvascular changes in the optic nerve head and macula.

8. Timed topical dexamethasone eye drops improve mitochondrial function to prevent severe retinopathy of prematurity.

9. Pterygium recurrence following preoperative topical Mitomycin C and 5-Fluorouracil eyedrops.

10. Comparison of postoperative topical interferon-α2b versus intraoperative mitomycin C for pterygium recurrence prevention: a randomized clinical trial.

11. Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits.

12. Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

13. Comparison of 0.02% atropine eye drops, peripheral myopia defocus design spectacle lenses, and orthokeratology for myopia control.

14. Retinal Function in Young Adults Following Topical Application of Levodopa to the Eye.

15. Safety and Tolerability of Anti-microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study.

16. Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials.

17. Topical Atropine for Myopia Control: A Review.

18. The evolution of cyclosporine treatments for treatment of ocular surface diseases.

19. Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application.

20. Small Molecule Topical Ophthalmic Formulation Development-Data Driven Trends & Perspectives from Commercially Available Products in the US.

21. The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sjögren's syndrome related dry eye.

22. The Ocular Penetration and Intraocular Pressure Lowering Effect of Topical Acetaminophen in the New Zealand White Rabbit.

23. A supramolecular hydrogel eye-drop alleviates inflammation via clathrin-mediated endocytosis.

24. Tolerability of Diquas LX on tear film and meibomian glands findings in a real clinical scenario.

25. Development of a Temperature and pH Dual-Sensitive In-Situ Gel for Treating Allergic Conjunctivitis.

26. [Efficacy of Combining Highly Aspherical Lenslets Spectacles With 0.01% Atropine Eye Drops in Myopia Control].

27. Pain perception during intravitreal injections is related to the timing of instilling anesthetic eyedrops.

28. Effectiveness of cyclosporine nanoemulsion eye drops in patients with mild-to-moderate dry eyes: objective and subjective evaluation.

29. Mathematical Models of Ocular Drug Delivery.

30. Lubratex eye ointment with polyethylene cover significantly reduces corneal abrasion in ICU patients: a randomized controlled trial.

31. Treatment of progressive myopia with 0.01% Atropine in children and adolescents: an Italian 4-year follow-up study.

32. Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium.

33. Evaluation of Pregabalin bioadhesive multilayered microemulsion IOP-lowering eye drops.

34. Effects of atropine eyedrops at ten different concentrations for myopia control in children: A systematic review on meta-analysis.

35. Neurokinin-1 Receptor Antagonism Reduces Nonallergic Ocular Redness in a Rabbit Model.

36. Successful management of dry eye disease with a new eye drop formulation combining hyaluronic acid, trehalose, and N-acetyl-aspartyl-glutamic acid (NAAGA).

37. Eyes on New Product Development.

38. An Evaluation of the Efficacy and Safety of Timolol Maleate 0.5% Microdrops Administered with the Nanodropper.

39. Polystyrene Sulfonate Resin as an Ophthalmic Carrier for Enhanced Bioavailability of Ligustrazine Phosphate Controlled Release System.

40. Ocular Pharmacology.

41. Efficacy of the topical antihistamine olopatadine in dogs with experimentally induced allergic conjunctivitis.

42. Physiologically Based Pharmacokinetic Modeling and Clinical Extrapolation for Topical Application of Pilocarpine on Eyelids: A Comprehensive Study.

43. Safety and tolerability of pooled human immune globulins after topical ophthalmic administration in New Zealand White rabbits.

44. The effect of three different mydriatic eye drops on retinal vessel diameters.

45. Dexamethasone Intracanalicular Insert for Clinically Significant Aqueous-Deficient Dry Eye: A Randomized Controlled Trial.

46. Sublingual administration of atropine eye drops for treating sialorrhea after stroke: A randomized controlled trial.

47. Topical bromfenac in VEGF-driven maculopathies: topical review and meta-analysis.

48. Prefilled Ophthalmic syringes - New Possibilities in Terminal Sterilization.

49. [Effectiveness of the Eye Care Protocol in the Intensive Care Unit Patients: A Randomized Controlled Trial].

50. Effects of combined intense pulsed light and cyclosporine 0.05% eyedrops in ocular surface matrix metalloproteinase-9 levels in patients with moderate-to-severe MGD.

Catalog

Books, media, physical & digital resources